Hot Deals:
a v thomas 13,300.00 (1.53 %) adtech 27.05 (0.19 %) agarwal bolts 1,201.00 (0.08 %) amol minechem 620.00 (1.64 %) anand i-power 20.00 anglo french 370.00 (-2.37 %) aricent 515.00 (0.98 %) arkfin investments 50.00 arohan 170.00 (-0.58 %) assam carbon 208.00 (-0.95 %) associated pigments 42.01 (0.02 %) atlas copco 10,000.00 (1.01 %) auckland international 130.00 (-3.70 %) axles 162.00 (1.25 %) balmer lawrie 197.00 (-1.50 %) bharat hotels 149.00 (-0.67 %) bima mandi 700.00 bira 91 750.00 (-2.85 %) boat 830.00 (3.75 %) c & s electric 471.00 (0.21 %) capgemini 12,100.00 (-0.82 %) care health 150.00 (2.04 %) carrier aircon 260.00 (1.96 %) cial 179.00 (0.56 %) csfbl 264.00 (-0.38 %) csk 168.00 (1.20 %) dalmia refract 82.00 (1.23 %) dsp merrill lynch 1,000.00 east india pharma 44.00 (2.33 %) eaton fluid 414.00 (2.22 %) electronica plastic 4,110.00 (0.24 %) elgi ultra 400.00 elofic 1,925.00 (0.84 %) esl steel 38.00 (2.70 %) fincare business 43.00 fincare sfbl 74.00 (1.37 %) fino paytech 155.00 (-1.90 %) flipkart 231,000.00 (0.00 %) frick india 2,800.00 (-3.45 %) gkn drive 1,161.00 (0.09 %) go digit gil 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdbfsl 625.00 (2.46 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,400.00 (2.70 %) hella india 375.00 (-0.53 %) hero fincorp 680.00 (-1.45 %) hicks 1,579.00 (-1.31 %) hira ferro 120.00 (-0.83 %) honeywell electrical 3,333.00 (-1.97 %) icex 0.10 (0.10 %) incred financial 100.00 india carbon 1,010.00 (1.00 %) india exposition 146.00 (0.69 %) indian potash 1,405.00 (0.36 %) indofil 703.00 (0.43 %) infinite computer 700.00 inkel 12.00 (-1.64 %) ixigo 72.00 (-2.70 %) jana sfbl 75.00 kel 460.00 (2.22 %) kial 107.00 (-2.73 %) kurlon limited 292.00 (0.69 %) lava 127.00 (0.79 %) manipal housing 72.50 (0.69 %) manjushree tech 990.00 (2.06 %) martin & harris 1,240.00 (-0.80 %) merino 2,775.00 (0.18 %) minosha 280.00 (-3.45 %) mitsubishi heavy 355.00 (1.43 %) mkcl 400.00 (-3.61 %) mobikwik 390.00 (-2.50 %) mohan meakin 1,210.00 (0.83 %) mohfl 8.10 (1.25 %) msei 1.00 (1.01 %) msil 57.00 (1.79 %) nayara energy 150.00 (-1.32 %) nayara energy ncd 250.00 ncdex 275.00 ncl buildtek 190.00 (-0.52 %) ncl holdings 53.00 (1.92 %) nse 3,100.00 (-1.59 %) orbis financial 81.00 (1.25 %) oswal minerals 65.00 (1.56 %) otis 3,600.00 (-2.70 %) oyo rooms 68.00 (-1.45 %) panasonic appliances 295.00 (0.68 %) panasonic avc 29.10 (0.34 %) paymate india 600.00 (-3.38 %) pharmeasy 29.00 (-3.01 %) philips domestic 605.00 (0.83 %) philips india 979.00 (-1.11 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 390.00 (-2.50 %) rasoi 31,400.00 (-1.88 %) reliance gic 340.00 resins plastics 414.00 (1.97 %) ring plus 405.00 (2.27 %) rrl 2,525.00 (-2.88 %) sab miller 305.00 (0.66 %) scottish assam 443.00 (-1.56 %) shriram life 251.00 (0.40 %) sigachi lab 40.10 (0.25 %) signify 1,161.00 (0.96 %) simpson & company 3,500,000.00 smile micro 52.00 (-1.89 %) sportskeeda 3,303.00 sterlite power 485.00 (-3.00 %) studds 850.00 (-2.30 %) svsml 430.00 (-2.27 %) t stanes 601.00 (0.17 %) tata capital 56.00 (1.82 %) tata tech 740.00 (2.78 %) teesta agro 60.00 (-1.64 %) trl krosaki 1,200.00 (-1.96 %) utkarsh coreinvest 127.00 (-2.31 %) vikram solar 55.50 (-0.89 %)
×

anglo french drugs and industries Limited

370.00
-2.37 %
Scrip Name
Anglo French
ISIN No.
INE570E01016
PAN No.
AAACA9756E
Face Value
10
No. of Outstanding Shares
1,212,687
Market Capitalization
44.87 Crore
Book value
156.017
P/BV
2.372
EPS
15.503
PE ratio
23.866
Available on
nsdlcdsl
ROFR Required
No

About Anglo-French Drugs & Industries Limited Unquoted Shares

Anglo – French Drugs & Industries Limited (AFDIL) is a pharmaceutical company established in 1923 based in Bengaluru. The company is mainly engaged in the manufacturing of pharmaceutical formulations. Pharmaceutical formulation is a process in which different chemical substances including the active drug are mixed with each other to produce a final medicinal product.

Anglo–French Drugs & Industries Limited is one of the most prominent pharmaceutical companies recognized not only in India but also at a global level. Anglo-French Drugs & Industries Limited is the first company to manufacture single vitamin injections and a combination of B-complex vitamins in India.

The company focuses mainly on vitamins, sleep inducing agents, antiepileptics and antioxidants, cold and cough preparations, protein food supplements, antibiotics, anti-inflammatory drugs, digestive enzymes, and calcium supplements.

Anglo–French Drugs & Industries Limited serves around 75,000 medical practitioners in India annually. The company has a well-distributed network of 24 clearing and forwarding agents and 1600 stockists. The products of Anglo-French Drugs & Industries Limited are available at over 50,000 stores in India. The company has a presence in 16 countries across Eastern Europe, South East Asia & Africa.

Equity shares of Anglo–French Drugs & Industries Limited are listed on the Metropolitan Stock Exchange of India (MSEI).

 

INCORPORATION DETAILS

CIN

L24230KA1923PLC010205

Registration Date

01 February 1923

Category/Sub-category of the Company

Company limited by shares

Address of the Registered office and contact details

No.41, 3rd Cross, V Block, SSI Area, Rajajinagar, Bengaluru – 560010, Karnataka

Telephone: 080-2315 6757

Name, Address, and Contact Details of

Registrar and Transfer Agent, if any

Canbank Computer Services Limited,

J.P. Royale, 1st Floor, #218, 2nd Main

Sampige Road, Malleswaram, Bengaluru-560003,

Telephone: 080-23469661/62

 

PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY

Name and Description of main products/services

NIC Code of the product/service

% to the total turnover of the Company

Manufacturing of Pharmaceutical Formulations

21002

100%

 

BOARD OF DIRECTORS

Mr. Abhay Kanoria (Chairman & Managing Director)

Mr. Uddhav Kanoria (President & Whole-time Director)

Mr. Nirbhay Kanoria (Whole-time Director)

Mr. Sanatkumar Manjunath Shirali (Independent Director)

Mr. Nalagath Ahmedali (Independent Director)

Mrs. Neha Gada (Independent Director)

Mr. Shashikant N More (Nominee Director)

Dr. Rajeshwar B Smarta (Additional Independent Director)

Mr. Rakesh P Kanyadi (Additional Non-Executive Director)

 

PARTICULARS OF SUBSIDIARY COMPANIES

Name of the Company

% of shares held

Anglo-French Drugs & Industries Private Limited, Singapore

100%

 

SHAREHOLDING PATTERN

(As of 31-03-2022)

S. No.

Shareholders’ Name

Number of shares

% of total Shares of the company

1

Promoter and promoter group

834855

64.642

2

Public

456645

35.358

 

Total

12,91,500

100

 

INDUSTRY OUTLOOK

Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment’s availability have helped India to manufacture pharma products at a very low cost.

The Indian healthcare market saw a 3 fold jump in terms of value. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19.

After the onset of COVID-19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector.

 

PROFIT and LOSS STATEMENT of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED (In Rs. Lakhs)

PARTICULARS

2022

2021

Revenue from Operations

16,532

15,378

EBITDA

1080

1,912

EBITDA margin

6.07%

12.4%

Finance Cost

427

529

Depreciation

290

246

Other Income

82

102

Profit Before Exceptional Items and Tax

224

963

Exceptional items

 -

 -

Current Tax

139

174

MAT Credit entitlement

(85)

 -

Deferred Tax

(18)

38

Profit After Tax (PAT)

224

963

PAT margin

1.35%

6.26%

EPS

12

58

 

BALANCE SHEET of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED (In Rs. Lakhs)

PARTICULARS

31st March 2022

31st March 2021

ASSETS

 

 

NON CURRENT ASSETS

 

 

Property,  Plant and Equipment

1327

1,285

Right of Use Assets

546

73

Intangible assets

3

3

Financial assets

19

8

Other non-current assets

22

48

TOTAL NON-CURRENT ASSETS

1917

1,417

CURRENT ASSETS

 

 

Inventories

3277

3,667

Trade receivables

3426

3,626

Cash and Cash Equivalents

50

64

Other bank balances

163

58

Other current financial assets

202

184

Tax assets

72

0

Other current assets

603

461

TOTAL CURRENT ASSETS

7793

8,060

TOTAL ASSETS

9710

9,477

EQUITY AND LIABILITIES

 

 

EQUITY

 

 

Equity share capital

129

129

Other Equity

1763

1,478

TOTAL EQUITY

1892

1,607

LIABILITIES

 

 

NON CURRENT LIABILITIES

 

 

Borrowings

2032

1,647

Other financial liabilities

311

311

Other non-current liabilities

607

 -

Employee benefit obligations

52

106

Tax Liabilities

20

38

TOTAL NON-CURRENT LIABILITIES

3021

2,102

CURRENT LIABILITIES

 

 

Borrowings

1481

2,324

Trade payables

2231

2,246

Other financial liabilities

894

1096

Employee benefits obligations

38

58

Current tax liabilities

139

34

Other current liabilities

 -

 -

TOTAL CURRENT LIABILITIES

4797

5,768

TOTAL LIABILITIES

7818

7,870

TOTAL EQUITY AND LIABILITIES

9710

9,477

 

PERFORMANCE OF THE COMPANY

The total revenue from operations of the company has increased by 7.50% from Rs. 15,378 lakhs in FY 2021 to Rs. 16,532 lakhs in FY 2022.

EBITDA of the company decreased significantly by 43.5% from Rs. 1,912 lakhs in FY 2021 to Rs. 1080 lakhs in FY 2022.

The net profit of the company has significantly decreased by 76.7% from Rs. 963 lakhs in FY 2021 to Rs. 224 lakhs in FY 2022.

The current ratio of the company as of 31st March 2022 was 1.62.

The debt-to-equity ratio of the company as of 31st March 2022 was 23.41.

The book value per share of the company as of 31st March 2022 stood at Rs.146.49.

Anglo-French Drugs & Industries Limited has not given any dividends for the past 5 years.

Annual Reports

2022-23

Download

2021-22

Download

2020-21

Download

Corporate Actions

2019-20

Download

2019-20

Download

2019-20

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha Support Pallavi